Gohei Yagi

3.2k total citations
93 papers, 2.4k citations indexed

About

Gohei Yagi is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gohei Yagi has authored 93 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Psychiatry and Mental health, 14 papers in Clinical Psychology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gohei Yagi's work include Schizophrenia research and treatment (47 papers), Bipolar Disorder and Treatment (22 papers) and Tryptophan and brain disorders (13 papers). Gohei Yagi is often cited by papers focused on Schizophrenia research and treatment (47 papers), Bipolar Disorder and Treatment (22 papers) and Tryptophan and brain disorders (13 papers). Gohei Yagi collaborates with scholars based in Japan, Canada and United States. Gohei Yagi's co-authors include Shigenobu Kanba, Toshio Nakaki, Masahiro Asai, Futoshi Shintani, Masashi Asai, Eiji Suzuki, Toshiya Inada, Ritsushi Kato, Masashi Nibuya and N. Kinoshita and has published in prestigious journals such as Journal of Neuroscience, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Gohei Yagi

90 papers receiving 2.3k citations

Peers

Gohei Yagi
Celeste A. Johns United States
Sukdeb Mukherjee United States
Hasan Herken Türkiye
Teruhiko Higuchi Japan
Robert H. Gerner United States
Dorotea Mück‐Šeler Croatia
Jogin H. Thakore United Kingdom
Philip A. Berger United States
Manolis Markianos Greece
R M Post United States
Celeste A. Johns United States
Gohei Yagi
Citations per year, relative to Gohei Yagi Gohei Yagi (= 1×) peers Celeste A. Johns

Countries citing papers authored by Gohei Yagi

Since Specialization
Citations

This map shows the geographic impact of Gohei Yagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gohei Yagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gohei Yagi more than expected).

Fields of papers citing papers by Gohei Yagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gohei Yagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gohei Yagi. The network helps show where Gohei Yagi may publish in the future.

Co-authorship network of co-authors of Gohei Yagi

This figure shows the co-authorship network connecting the top 25 collaborators of Gohei Yagi. A scholar is included among the top collaborators of Gohei Yagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gohei Yagi. Gohei Yagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Takefumi, Hiroyoshi Takeuchi, Shinichiro Nakajima, et al.. (2010). Magnitude of Rater Differences in Assessment Scales for Schizophrenia. Journal of Clinical Psychopharmacology. 30(5). 607–611. 6 indexed citations
2.
Suzuki, Takefumi, Hiroyuki Uchida, Hiroyoshi Takeuchi, et al.. (2009). Augmentation of atypical antipsychotics with valproic acid. An open‐label study for most difficult patients with schizophrenia. Human Psychopharmacology Clinical and Experimental. 24(8). 628–638. 36 indexed citations
3.
4.
Uchida, Hiroyuki, Takefumi Suzuki, David C. Mamo, et al.. (2008). Effects of Age and Age of Onset on Prescribed Antipsychotic Dose in Schizophrenia Spectrum Disorders: A Survey of 1,418 Patients in Japan. American Journal of Geriatric Psychiatry. 16(7). 584–593. 40 indexed citations
5.
Suzuki, Takefumi, Hiroyuki Uchida, Hiroyoshi Takeuchi, et al.. (2005). Simplifying psychotropic medication regimen into a single night dosage and reducing the dose for patients with chronic schizophrenia. Psychopharmacology. 181(3). 566–575. 17 indexed citations
6.
Yamada, Kazuo, Koichiro Watanabe, Keita Yamauchi, et al.. (2005). Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study. Psychiatry Research. 141(1). 61–69. 53 indexed citations
7.
Yamada, Kazuo, Gohei Yagi, & Shigenobu Kanba. (2003). Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: A randomized controlled trial. Psychiatry and Clinical Neurosciences. 57(2). 183–187. 13 indexed citations
8.
Uchida, Hiroyuki, Takefumi Suzuki, Kenji F. Tanaka, et al.. (2003). Recurrent Episodes of Perceptual Alteration in Patients Treated With Antipsychotic Agents. Journal of Clinical Psychopharmacology. 23(5). 496–499. 13 indexed citations
9.
Suzuki, Takefumi, Hiroyuki Uchida, Koichiro Watanabe, Gohei Yagi, & Haruo Kashima. (2003). A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(2). 361–369. 22 indexed citations
10.
Shintani, Futoshi, et al.. (2001). Combination of inflammatory cytokines increases nitrite and nitrate levels in the paraventricular nucleus of conscious rats. Brain Research. 905(1-2). 12–20. 24 indexed citations
11.
12.
Kanba, Shigenobu, Hiroshi Manki, Futoshi Shintani, et al.. (1998). Aberrant interleukin-2 receptor-mediated blastoformation of peripheral blood lymphocytes in a severe major depressive episode. Psychological Medicine. 28(2). 481–484. 15 indexed citations
13.
Yamada, Kazuo, Shigenobu Kanba, Zucheng Wang, et al.. (1996). Improvement of schizophrenic symptoms and changes in plasma HVA concentrations, plasma anti‐D2 and anti‐5‐HT2 receptor activities with clozapine. Psychiatry and Clinical Neurosciences. 50(5). 291–294.
14.
Manki, Hiroshi, Shigenobu Kanba, Taro Muramatsu, et al.. (1996). Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders. Journal of Affective Disorders. 40(1-2). 7–13. 89 indexed citations
15.
Yamada, Kazuo, et al.. (1996). Effectiveness of Shakuyaku‐kanzo‐to in neuroleptio induced hyperprolactinemia: A preliminary report. Psychiatry and Clinical Neurosciences. 50(6). 341–342. 13 indexed citations
16.
Yamada, Kazuo, et al.. (1996). Nilvadipine Is Effective for Chronic Schizophrenia in a Double-Blind Placebo-Controlled Study. Journal of Clinical Psychopharmacology. 16(6). 437–439. 14 indexed citations
17.
Nibuya, Masashi, Shigenobu Kanba, Eiji Suzuki, et al.. (1995). Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement. Biological Psychiatry. 38(1). 50–56. 27 indexed citations
18.
Yamada, Kazuo, et al.. (1995). Effectiveness of nilvadipine in two cases of chronic schizophrenia. Psychiatry and Clinical Neurosciences. 49(4). 237–238. 4 indexed citations
19.
Inada, Toshiya, et al.. (1995). Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients. Psychiatric Genetics. 5(3). 113–116. 20 indexed citations
20.
Kanba, Shigenobu, Gohei Yagi, Toshio Nakaki, Ryuji Kato, & Elliott Richelson. (1991). Potentiation by a sodium channel activator of effects of lithium ion on cyclic AMP, cyclic GMP and inositol phosphates. Neuropharmacology. 30(5). 497–500. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celeste A. Johns Breakdown of academic impact, for papers by Sukdeb Mukherjee Breakdown of academic impact, for papers by Hasan Herken Breakdown of academic impact, for papers by Teruhiko Higuchi Breakdown of academic impact, for papers by Robert H. Gerner Breakdown of academic impact, for papers by Dorotea Mück‐Šeler Breakdown of academic impact, for papers by Jogin H. Thakore Breakdown of academic impact, for papers by Philip A. Berger Breakdown of academic impact, for papers by Manolis Markianos Breakdown of academic impact, for papers by R M Post
Rankless by CCL
2026